You are here: Home » Current Affairs » Coronavirus » News
IT raids in Delhi, Jaipur in tax evasion case against Rajasthan group
In pics: Here's all you need to know about reporting a cybercrime in India
Business Standard

Banaras Hindu University to study Use of Ashwagandha on Covid-19 warriors

IMS in BHU will study use of Ashwagandha as a test drug for prophylactic use among frontline health workers and Yashtimadhu for supplementary therapy as a standard treatment of Corona patients

Coronavirus | ICMR | Banaras Hindu University

IANS  |  Varanasi 

BHU, benaras, varanasi
Photo: Wikimedia Commons

The Institute of Medical Sciences (IMS) in the (BHU) will study the use of Ashwagandha (Withania somnifera) as a test drug for prophylactic use among frontline health workers and Yashtimadhu (Glycyrrhiza glabra) for supplementary therapy as a standard treatment of Corona patients with mild and moderate symptoms.

According to Professor Anand Chaudhary, head of the department of Rasa Shastra, of Ayurveda faculty IMS-BHU and centre coordinator for the project, "As a part of the project of ministry of AYUSH, Indian Council of Medical Research and Council of Scientific and Industrial Research, the university was assigned the task of conducting studies on Ashwagandha and Yashtimadhu."

He said, "Ashwagandha will be tested for study in prophylactic use among frontline health workers of SSL Hospital of BHU and other healthcare workers, while Yashtimadhu will be tested as drug for adjunct therapy with the standard treatment of conventional medicine on Covid-19 patients under treatment in BHU with mild and moderate symptoms."

Chaudhary said, "The ministry, and CSIR have selected Cadila Pharmaceutical Limited, Ahmedabad and Ardent Clinical Research Services, Pune, as contract research organization (CRO) and nodal agencies for the projects of prophylaxis and adjunct therapy, respectively, to take care of the projects sanctioned to the BHU and other medical institutions in Lucknow, Bengaluru, Mumbai, Thiruvananthapuram, Gurugram, Jodhpur and Jaipur."

The objectives of the projects are to explore the efficacy of ayurvedic interventions in Covid-19 patients on standards of conventional biomedical researches, he said, adding that each centre has formed joint teams of investigators from both allopathy and ayurvedic faculties.

Prof Chaudhary said the consignment of Ashwagandha and Yashtimadhu has been received by BHU while funds for further studies and data collection to be done in six weeks, are expected to be allocated within a week.

He said that the compiled data of these studies will be submitted for validation on contemporary scientific standards by global health agencies like WHO for the acceptance of Ayurveda as a system of medicine worldwide.

BHU, which is among 15 institutions of the country to contribute in this project, is providing level-3 facility at its hospitals for Covid-19 patients while it is also conducting laboratory testing for novel infection of many east Uttar Pradesh districts.



(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Mon, July 13 2020. 11:28 IST